A detailed history of Yousif Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Yousif Capital Management, LLC holds 17,025 shares of UTHR stock, worth $6.25 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
17,025
Previous 19,208 11.37%
Holding current value
$6.25 Million
Previous $6.12 Million 0.29%
% of portfolio
0.07%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$311.04 - $363.55 $679,000 - $793,629
-2,183 Reduced 11.37%
17,025 $6.1 Million
Q2 2024

Jul 31, 2024

SELL
$228.26 - $319.04 $622,693 - $870,341
-2,728 Reduced 12.44%
19,208 $6.12 Million
Q1 2024

Apr 26, 2024

SELL
$210.76 - $249.51 $145,002 - $171,662
-688 Reduced 3.04%
21,936 $5.04 Million
Q4 2023

Feb 01, 2024

SELL
$214.88 - $256.94 $21,702 - $25,950
-101 Reduced 0.44%
22,624 $4.97 Million
Q3 2023

Oct 30, 2023

SELL
$211.82 - $248.24 $261,597 - $306,576
-1,235 Reduced 5.15%
22,725 $5.13 Million
Q2 2023

Aug 02, 2023

SELL
$205.19 - $232.99 $25,853 - $29,356
-126 Reduced 0.52%
23,960 $5.29 Million
Q1 2023

May 02, 2023

SELL
$212.99 - $276.17 $25,558 - $33,140
-120 Reduced 0.5%
24,086 $5.39 Million
Q4 2022

Jan 09, 2023

BUY
$205.95 - $280.43 $63,844 - $86,933
310 Added 1.3%
24,206 $0
Q3 2022

Nov 04, 2022

SELL
$203.3 - $244.17 $448,886 - $539,127
-2,208 Reduced 8.46%
23,896 $5 Million
Q2 2022

Aug 01, 2022

BUY
$174.81 - $241.14 $144,218 - $198,940
825 Added 3.26%
26,104 $6.15 Million
Q1 2022

May 12, 2022

BUY
$166.16 - $213.96 $145,057 - $186,787
873 Added 3.58%
25,279 $4.54 Million
Q4 2021

Jan 31, 2022

BUY
$184.32 - $216.08 $4.5 Million - $5.27 Million
24,406 New
24,406 $5.27 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.